Cannabis Rescheduling

2 US House Democrats Nudge DEA to ‘Swiftly’ Reschedule Cannabis

Reps. Jerry Nadler and Frank Pallone Jr., both ranking members, wrote a letter to the attorney general and DEA administrator.

Medical Marijuana Act Signed by Biden Would Hinder Research Under Rescheduling

The Medical Marijuana and Cannabidiol Research Expansion Act’s requirements would remain under Schedule III, a congressional researcher says.

The Complex Impact of Rescheduling Cannabis on Advertising

The penalties for advertising Schedule I drugs don’t apply to Schedule III drugs, but cannabis businesses could be left in a precarious position.

Trump Signals Support for Federal Cannabis Rescheduling, Banking Reform

The GOP presidential candidate said he will focus on unlocking the ‘medical uses of marijuana to a Schedule 3 drug’ if elected in November.

Ohio Cannabis, Federal Rescheduling, GTI’s Former Partnership With Bobby George Lead CBT’s Top Stories in August

From Ohio’s sales launch to a rescheduling hearing and to a man facing nine felony charges, don’t miss out on the most-read articles this month.

Cannabis Rescheduling No Longer on Fast Track; Hearing Scheduled For December

The DEA will not issue a final rule before the November election now that Administrator Anne Milgram granted an administrative law judge hearing.

Rescheduling Update: How Long Is the Wait? What’s Next?

Government affairs and policy expert David Mangone tells us what we can expect from the DEA as weeks pass following the public comment period, including insights on the DEA’s final review and if a hearing is likely to be granted.

Kamala Harris Picks Pro-Cannabis Minnesota Governor as Running Mate

Gov. Tim Walz has a long track record of supporting cannabis reform, including during his 12 years as a U.S. House member.

Cannabis Rescheduling Nearly ‘Done Deal,’ Story Cannabis CEO Says

Jason Vedadi, the former executive chairman for Harvest Health before its acquisition by Trulieve, talks exclusively with CBT on what he expects from federal rescheduling as the industry awaits the DEA’s final determination.

Ohio’s Adult-Use Licensing Process Leads CBT’s Top Stories in July

California’s deadly pesticide contamination, federal cannabis rescheduling and CRISPR gene editing were also among the most-read articles this month.

43,000 Comments Filed on Cannabis Rescheduling Proposal as Public Period Closes

The Drug Enforcement Administration will now weigh these comments and potentially hold administrative law hearings before issuing a final rule.

VP Harris: ‘We Need to Legalize Marijuana’

NORML Regional Coordinator Chris Goldstein takes us inside the closed-door White House roundtable discussion on criminal justice and cannabis drug policy and shares why he feels this is ‘the beginning of the end of the drug war.’

Page 1 of 9

Next Page